F
Francesca Mallamaci
Researcher at National Research Council
Publications - 397
Citations - 20221
Francesca Mallamaci is an academic researcher from National Research Council. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 66, co-authored 356 publications receiving 17845 citations. Previous affiliations of Francesca Mallamaci include Tokai University & United Hospitals.
Papers
More filters
Journal ArticleDOI
A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients
Gian Paolo Rossi,Giampaolo Bernini,C. Caliumi,Giovambattista Desideri,Bruno Fabris,Claudio Ferri,Chiara Ganzaroli,Gilberta Giacchetti,Claudio Letizia,Mauro Maccario,Francesca Mallamaci,Massimo Mannelli,Mee-Jung Mattarello,A. Moretti,Gaetana Palumbo,Gabriele Parenti,Enzo Porteri,Andrea Semplicini,Damiano Rizzoni,Ermanno Rossi,Marco Boscaro,Achille C. Pessina,Franco Mantero,Papy Study Investigators +23 more
TL;DR: In newly diagnosed hypertensive patients referred to hypertension centers, the prevalence of APA is high (4.8%) and the availability of AVS is essential for an accurate identification of the adrenocortical pathologies underlying PA.
Journal ArticleDOI
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study
Carmine Zoccali,Stefanie M. Bode-Böger,Francesca Mallamaci,F. Benedetto,Giovanni Tripepi,Lorenzo Malatino,Alessandro Cataliotti,Ignazio Bellanuova,Isabella Fermo,Jürgen C. Frölich,Rainer H. Böger +10 more
TL;DR: In haemodialysis patients, plasma ADMA is a strong and independent predictor of overall mortality and cardiovascular outcome, and lends support to the hypothesis that accumulation of AD MA is an important risk factor for cardiovascular disease in chronic renal failure.
Journal ArticleDOI
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
Carmine Zoccali,Francesca Mallamaci,Giovanni Tripepi,Francesco A. Benedetto,Sebastiano Cutrupi,Saverio Parlongo,Lorenzo Malatino,Graziella Bonanno,Giuseppe Seminara,Francesco Rapisarda,Pasquale Fatuzzo,Michele Buemi,Giacomo Nicocia,Sachiyo Tanaka,Noriyuki Ouchi,Shinji Kihara,Tohru Funahashi,Yuji Matsuzawa +17 more
TL;DR: Plasma ADPN levels are an inverse predictor of cardiovascular outcomes among patients with end-stage renal disease and are related to several metabolic risk factors in a manner consistent with the hypothesis that this protein acts as a protective factor for the cardiovascular system.
Journal ArticleDOI
Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease
Carmine Zoccali,Francesca Mallamaci,Saverio Parlongo,Sebastiano Cutrupi,Francesco A. Benedetto,Giovanni Tripepi,Graziella Bonanno,Francesco Rapisarda,Pasquale Fatuzzo,Giuseppe Seminara,Alessandro Cataliotti,Benedetta Stancanelli,Lorenzo Malatino +12 more
TL;DR: Sympathetic nerve overactivity is associated with mortality and cardiovascular outcomes in ESRD and controlled trials with antiadrenergic drugs are needed to determine whether interference with the sympathetic system could reduce the high cardiovascular morbidity and mortality in dialysis patients.
Journal ArticleDOI
Atherosclerotic Renal Artery Stenosis: Epidemiology, Cardiovascular Outcomes, and Clinical Prediction Rules
TL;DR: A clinical rule was derived that predicted renal arterial stenosis as efficiently as renal scintigraphy and can perform as accurately as more complex tests in the detection of renal artery stenosis when tested in a systematic and quantitative manner.